NASDAQ · Biotechnology
Quantum-Si Incorporated (QSI) Stock
$1.22
-4.69%
NASDAQ: QSI
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Jun 16, 2026
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
Business Wire · Jun 10, 2026
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
Business Wire · Jun 3, 2026
Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?
Simply Wall St. · May 31, 2026
Quantum-Si Q1 Earnings Call Highlights
MarketBeat · May 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held10.51%
Institutions Held29.97%
Institutions Float Held33.49%
Peer Comparison
About Quantum-Si Incorporated
Quantum-Si Incorporated is led by CEO Jeffrey Alan Hawkins, publicly traded since 2020.
Quantum-Si Incorporated (QSI) stock trades at $1.22 with a market capitalization of $241.34M. The stock is valued at a price-to-earnings (P/E) ratio of -3.34, price-to-book of 1.87, price-to-sales of 191.04. Over the past 52 weeks the stock has ranged between $0.69 and $3.10, and currently trades 60.6% below its 52-week high.
On profitability, Quantum-Si Incorporated generates a return on equity (ROE) of -47.12%, return on capital employed of -52.40%, an operating margin of -4850.00%, a net profit margin of -56.06%.